DEF 14A

Company

Definium Therapeutics, Inc.

Filed

April 23, 2025

Period of Report

June 12, 2025

Accession Number

0001104659-25-038010

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →